• Mashup Score: 1
    Holistic approach to CLL management - 4 year(s) ago

    Kostas Stamatopoulos, MD, PhD, of the Center for Research and Technology Hellas, Thermi, Greece, outlines the importance of a holistic…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      VIDEO: Find out the importance of holistic approaches to manage #CLL w/ Kostas Stamatopoulos: https://t.co/rpCCz3lfQa @VJHemOnc @EHA_Hematology #EHA25 #HemOnc #Oncoalert #EHAtrending #EHA25Virtual @OncoAlert #Leusm #Leukemia

  • Mashup Score: 0
    PEGASUS: APL-2 for PNH - 4 year(s) ago

    Peter Hillmen, MBChB, FRCP, FRCPath, PhD, of the University of Leeds, Leeds, UK, discusses a Phase III study (NCT03500549) evaluating…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      VIDEO: New clinical trials for patients with #PNH w/ Peter Hillmen of @UniversityLeeds : https://t.co/TWqeB0ZaBF @VJHemOnc @EHA_Hematology #EHA25 #HemOnc #Oncoalert #EHAtrending #EHA25Virtual @OncoAlert #CTsm https://t.co/hWsZBdTSvZ

  • Mashup Score: 0
    Future of CAR-T - 4 year(s) ago

    Wendy Osborne, MBBS (Hons), MRCP, FRCPath, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK, provides an outlook…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      VIDEO: Find out the future of CAR-T therapy w/ Wendy Osborne of @NewcastleHosps: https://t.co/GTpQSByw94 @VJHemOnc @EHA_Hematology #EHA25 #HemOnc #Oncoalert #EHAtrending #EHA25Virtual #tcellrx @OncoAlert

  • Mashup Score: 0
    Advances in risk-stratification in pediatric ALL - 4 year(s) ago

    Anthony Moorman, PhD, Newcastle University, Newcastle, UK touches on advances in risk-stratification in pediatric acute lymphoblastic leukemia (ALL) including the…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      VIDEO: Advances on risk stratification for pediatric #ALL w/ Anthony Moorman of @UniofNewcastle: https://t.co/ZRYVXhU1rq @VJHemOnc @EHA_Hematology #EHA25 #HemOnc #Oncoalert #EHAtrending #EHA25Virtual @OncoAlert #Leusm #Leukemia

  • Mashup Score: 0
    Outcomes of limited stage peripheral T-cell lymphoma - 4 year(s) ago

    Ahmed Ludvigsen Al-Mashhadi, MD, of the Aalborg University Hospital, Aalborg, Denmark, discusses a study presented by the NORDIC lymphoma group…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      VIDEO: NORDIC lymphoma group in limited stage peripheral T-cell #Lymphoma study explained w/ Ahmed Ludvigsen Al-Mashhadi: https://t.co/sETKuj2My7 @VJHemOnc @EHA_Hematology #EHA25 #HemOnc #Oncoalert #EHAtrending #EHA25Virtual @OncoAlert #Lymsm https://t.co/n8tatXzMMw

  • Mashup Score: 1
    Ruxolitinib discontinuation syndrome: real-world data - 4 year(s) ago

    Francesca Palandri, PhD, MD, of the University Hospital, Bologna, Italy, discusses real-world data on the incidence of ruxolitinib discontinuation syndrome…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      VIDEO: Real world data on #RDS in #Myelofibrosis w/ Francesca Palandri of University of Bologna: https://t.co/BC7ZLGpuAK @VJHemOnc @EHA_Hematology #EHA25 #HemOnc #Oncoalert #EHAtrending #EHA25Virtual @OncoAlert #MPNsm #RealWorldData

  • Mashup Score: 0
    Identifying high-risk AML - 4 year(s) ago

    Jeffrey Lancet, MD, of H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, discusses the identification of high-risk acute…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      VIDEO: Identifying high risk #AML w/ Jeffrey Lancet of @MoffittResearch: https://t.co/qsxYNl3296 @VJHemOnc @EHA_Hematology #EHA25 #HemOnc #Oncoalert #EHAtrending #EHA25Virtual @OncoAlert #Leusm #Leukemia

  • Mashup Score: 0
    Front-line and R/R updates in CLL from EHA - 4 year(s) ago

    Peter Hillmen, MBChB, FRCP, FRCPath, PhD, of the University of Leeds, Leeds, UK, explores highlights in frontline chronic lymphocytic leukemia…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      VIDEO: Front-line and R/R updates in #CLL from EHA 2020 w/ Peter Hillmen of @UniversityLeeds https://t.co/gv2TZThien @VJHemOnc @EHA_Hematology #EHA25 #HemOnc #Oncoalert #EHAtrending #EHA25Virtual @OncoAlert #Leusm #Leukemia

  • Mashup Score: 1
    CPX-351 for high-risk AML - 4 year(s) ago

    Thomas Cluzeau, MD, PhD, Central University Hospital of Nice, Nice, France, outlines therapies for poor-risk acute myeloid leukemia (AML), including…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      VIDEO: CPX-351 for high-risk #AML w/ Thomas Cluzeau of @CHUdeNice: https://t.co/nHPHqTZYnq @VJHemOnc @EHA_Hematology #EHA25 #HemOnc #Oncoalert #EHAtrending #EHA25Virtual @OncoAlert #Leukemia #Leusm #CTsm

Load More